To explore if SH3BP1 combined with MVD was an independent clinical predictor of HCC outcome, the predictive value of this combined parameter was evaluated in another independent validation cohort of 112 HCC patients. The gene discussed is SH3BP1; the disease is hepatocellular carcinoma.